Dr. McCune completed a Doctorate of Pharmacy, an oncology residency, and a pharmacokinetics postdoctoral fellowship at the University of North Carolina.  Following that, she did a summer sabbatical in population pharmacokinetics at the University of Buffalo. Dr. McCune is a Professor in Hematologic Malignancies and Translational Sciences at the Beckman Research Institute of the City of Hope. She also serves as the Director of Research for the Hematopoietic Cell Transplant Program within City of Hope’s National Medical Center.  She is a clinical pharmacologist whose research team combines pharmacokinetic modeling with -omics tools. She studies the clinical use of anti-cancer drugs as well as drugs that suppress the immune system to prevent or treat cancer.  In addition to that, her team evaluates the influence of constitutional genomics or metabolomics on an individual’s drug response. Since 2007 she has served as a Principal Investigator for major National Institutes of Health grants for personalized medicine studies in children and adults with cancer. Dr. McCune has also served on various national committees, including various Study Sections within National Institute of Health’s Center for Scientific Review